ROMILKIMAB

UNII:	O8HNJ174XS
Type:	INGREDIENT SUBSTANCE
Formula:
Preferred Substance Name:	ROMILKIMAB
GSRS Full Record:	O8HNJ174XS i

1399584-78-1
HUTBTI3_2_1
IMMUNOGLOBULIN G4, BISPECIFIC, ANTI-(HUMAN INTERLEUKIN 4/INTERLEUKIN 13)(HUMANIZED CLONES HU8D4-8-AND HUBB13-CONTG. .GAMMA.4-CHAIN), DISULFIDE WITH HUMANIZED CLONES HU8D4-8-AND HUBB13-CONTG. .KAPPA.-CHAIN, DIMER
IMMUNOGLOBULIN G4-KAPPA, ANTI-(HOMO SAPIENS INTERLEUKIN-13 (IL-13)) AND ANTI-(HOMO SAPIENS INTERLEUKIN-4 (B-CELL STIMULATORY FACTOR 1, BINETRAKIN, IL-4)) CHIMERIC AND HUMANIZED MONOCLONAL ANTIBODY, BISPECIFIC, TETRAVALENT .GAMMA.1 HEAVY CHAIN (1-577) (VH ANTI-IL-13 (MUS MUSCULUS IGHV267*01 (84%) (IGHD)-IGHJ4*01 (94%) / HOMO SAPIENS IGHV2-26*01 (60%) (IGHD)-IGHJ1*01 (91%))) (8.7.12) (1-118) BIS(TETRAGLYCYL-SERYL)- LINKER (119-128) (VH ANTI-IL-4 (MUS MUSCULUS IGHV1S127*01 (82%) (IGHD)-IGHJ1*01 (88%) / HOMO SAPIENS IGHV1-46*01 (68%) (IGHD)-IGHJ4*01 (87%))) (8.8.16) (129-251) -HOMO SAPIENS IGHG4*01 (HINGE(S10>P(359)), CH2(L5>E(366)), CH3(K107>DEL(578))) (252-577)) (265-335')-DISULFIDE WITH .KAPPA. LIGHT CHAIN (1'-335') (V-KPPA ANTI-IL-13 (MUS MUSCULUS IGKV310*01 (93%) IGKJ1*01 (100%) / HOMO SAPIENS IGKV4-1*01 (72%) IGKJ4*01 (91%)) (10.3.9) (1'-111') BIS(TETRAGLYCYL-SERYL)- LINKER (112'-121') (HUMANIZED V-KAPPA ANTI-IL-4 (HOMO SAPIENS IGKV1-12*01 (77%) IGKJ2*02 (91%)) (6.3.9) (122'-228')) -HOMO SAPIENS IGKC*01 (229'-335')) DIMER (357-357'':360-360'')-BISDISULFIDE
ROMILKIMAB [USAN]
Romilkimab [WHO-DD]
SAR-156597
SAR156597
romilkimab [INN]

Note

UNIIs are generated based on scientific identity characteristics using ISO 11238 data elements. UNII availability does not imply any regulatory review or approval. Synonyms and mappings are based on the best public information available at the time of publication. Please report any problems/errors associated with this data to FDA-SRS@fda.hhs.gov.

ROMILKIMAB

Synonyms and Mappings

Resources